Roholla Hemmati
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Roholla Hemmati has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Dorsa Bahrami Zanjanbar
Pharmaceutical Science Research Center, Tehran Medical Sciences Islamic Azad University Tehran Iran
2 shared publications Abbas Soleimani
Mostafa Khomeini Cardiovascular and Research Hospital , Ilam University of Medical Sciences , Ilam , Iran
1 shared publication- Abbas Soleimani
Mostafa Khomeini Hospital Cardiovascular Research Center School of Medicine Ilam University of Medical Sciences Ilam Iran
1 shared publication Mohammad Iman Shishesaz
Medical Research Committee , Iran University of Medical Sciences , Tehran , Iran
1 shared publicationMohanna Parvenous
School of Medicine Iran University of Medical Sciences Tehran Iran
1 shared publicationSeyed Hossein Kia
Department of Cardiology School of Medicine Ilam University of Medical Sciences Ilam Iran
1 shared publication
Latest Publications
- Open Access
- 16 December 2025
- Published by Wiley in Obesity Science & Practice
- Vol. 11 (6)
Body Mass Index and Its Influence on Electrocardiographic Parameters in Healthy and Cardiovascular Patients
Objective: Cardiovascular diseases (CVDs) are a significant cause of mortality worldwide. Smoking, unhealthy diets, physical inactivity, and psychological stress are the main lifestyle factors associated with CVDs. This study was designed to investigate the relationship between electrocardiographic (ECG) changes and various body mass index (BMI) categories, considering demographic characteristics of the participants, such as age, gender, height, and weight. Methods: This cross‐sectional study was conducted on 964 patients attending Mostafa Khomeini Hospital, Ilam, Iran. Pearson correlation coefficients and regression models were employed using SPSS v. 24 to assess the relationship between BMI and ECG parameters recorded using a 12‐lead ECG. Results: A 10‐cm increase in height (165 ± 14) was associated with a 0.089 ms decrease in the PR interval, while a 5‐kg weight gain resulted in a 0.20 ms increase in the PR interval ( p = 0.49). The QRS interval increased by 2 and 0.03 ms, with a 10 cm height and 5 kg weight gain, respectively. The QT interval remained stable with changes in height but decreased by 1.34 ms with a 5‐kg increase in weight. Conclusion: The findings of this study suggest that ECG parameters are influenced by BMI and may be related to cardiovascular risks. An increase in PR and QRS intervals, a decrease in QRS voltage, and alterations in the ST segment and QT interval underscore the importance of maintaining a healthy BMI to reduce the risk of CVD. This message encourages proactive lifestyle changes to improve heart health.
- 16 December 2025
- Published by Wiley in Obesity Science & Practice
- Vol. 11 (6)
Open AccessBody Mass Index and Its Influence on Electrocardiographic Parameters in Healthy and Cardiovascular Patients
Objective: Cardiovascular diseases (CVDs) are a significant cause of mortality worldwide. Smoking, unhealthy diets, physical inactivity, and psychological stress are the main lifestyle factors associated with CVDs. This study was designed to investigate the relationship between electrocardiographic (ECG) changes and various body mass index (BMI) categories, considering demographic characteristics of the participants, such as age, gender, height, and weight. Methods: This cross‐sectional study was conducted on 964 patients attending Mostafa Khomeini Hospital, Ilam, Iran. Pearson correlation coefficients and regression models were employed using SPSS v. 24 to assess the relationship between BMI and ECG parameters recorded using a 12‐lead ECG. Results: A 10‐cm increase in height (165 ± 14) was associated with a 0.089 ms decrease in the PR interval, while a 5‐kg weight gain resulted in a 0.20 ms increase in the PR interval ( p = 0.49). The QRS interval increased by 2 and 0.03 ms, with a 10 cm height and 5 kg weight gain, respectively. The QT interval remained stable with changes in height but decreased by 1.34 ms with a 5‐kg increase in weight. Conclusion: The findings of this study suggest that ECG parameters are influenced by BMI and may be related to cardiovascular risks. An increase in PR and QRS intervals, a decrease in QRS voltage, and alterations in the ST segment and QT interval underscore the importance of maintaining a healthy BMI to reduce the risk of CVD. This message encourages proactive lifestyle changes to improve heart health.
- 27 December 2024
- Published by Walter de Gruyter GmbH in Journal of Complementary and Integrative Medicine
- Vol. 22 (1) , 173-180
The impact of Omega-3 supplementation on arrhythmia reduction in acute coronary syndrome patients: a randomized clinical trial
Background and Objectives: Cardiovascular diseases (CVDs), including acute coronary syndrome (ACS), represent a major global health challenge. Arrhythmias such as ventricular tachycardia (VT), ventricular fibrillation (VF), atrial fibrillation (AF), premature ventricular contractions (PVCs), and premature atrial contractions (PACs) frequently complicate ACS, needing effective management strategies. Omega-3 fatty acids have shown potency in preventing sudden cardiac death by modulating arrhythmias, but their acute effects in ACS patients remain controversial. This study aimed to evaluate the impact of Omega-3 supplementation on reducing common arrhythmias among ACS patients. Methods: A randomized clinical trial involving 74 ACS patients was conducted. Participants were randomly assigned to receive either 1 gr of Omega-3 daily or placebo (olive oil capsules) for five days. Arrhythmia frequencies (AF, PVCs, PACs, VT, VF) were monitored using daily ECGs, and statistical analyses were performed using SPSS software (version 24). Results: Over the five days, patients receiving Omega-3 showed significant reductions in the occurrence of AF (26.66–11.66 %, p=0.015), PACs (21.66–3.33 %, p=0.043), and PVCs (36.66–3.33 %, p=0.021) compared to the control group. The frequency of VT and VF cases was low, with only one VT case in the Omega-3 group, which resolved without intervention after the second day. Conclusions: This study highlights the potential of Omega-3 fatty acids as adjunct therapy for arrhythmia management post-ACS, particularly in reducing AF, PACs, and PVCs. However, the minimal effects on VF and VT and the lack of thorough statistical analysis for these arrhythmias warrant further investigation.
- 27 December 2024
- Published by Walter de Gruyter GmbH in Journal of Complementary and Integrative Medicine
- Vol. 22 (1) , 173-180
The impact of Omega-3 supplementation on arrhythmia reduction in acute coronary syndrome patients: a randomized clinical trial
Background and Objectives: Cardiovascular diseases (CVDs), including acute coronary syndrome (ACS), represent a major global health challenge. Arrhythmias such as ventricular tachycardia (VT), ventricular fibrillation (VF), atrial fibrillation (AF), premature ventricular contractions (PVCs), and premature atrial contractions (PACs) frequently complicate ACS, needing effective management strategies. Omega-3 fatty acids have shown potency in preventing sudden cardiac death by modulating arrhythmias, but their acute effects in ACS patients remain controversial. This study aimed to evaluate the impact of Omega-3 supplementation on reducing common arrhythmias among ACS patients. Methods: A randomized clinical trial involving 74 ACS patients was conducted. Participants were randomly assigned to receive either 1 gr of Omega-3 daily or placebo (olive oil capsules) for five days. Arrhythmia frequencies (AF, PVCs, PACs, VT, VF) were monitored using daily ECGs, and statistical analyses were performed using SPSS software (version 24). Results: Over the five days, patients receiving Omega-3 showed significant reductions in the occurrence of AF (26.66–11.66 %, p=0.015), PACs (21.66–3.33 %, p=0.043), and PVCs (36.66–3.33 %, p=0.021) compared to the control group. The frequency of VT and VF cases was low, with only one VT case in the Omega-3 group, which resolved without intervention after the second day. Conclusions: This study highlights the potential of Omega-3 fatty acids as adjunct therapy for arrhythmia management post-ACS, particularly in reducing AF, PACs, and PVCs. However, the minimal effects on VF and VT and the lack of thorough statistical analysis for these arrhythmias warrant further investigation.